Allikmets K, Parik T, Teesalu R
Department of Cardiology, University of Tartu, Estonia.
J Intern Med. 1996 Jan;239(1):49-55. doi: 10.1046/j.1365-2796.1996.414756000.x.
To study the relationships between plasma renin activity and metabolic cardiovascular risk factors in patients with essential hypertension.
Patients with uncomplicated essential hypertension (n = 36) with a diastolic blood pressure of 95-115 mmHg were studied. Assessment of plasma renin activity (PRA) related to urinary sodium excretion was used to define subgroups with high (n = 12), medium (n = 16) and low renin profiles (n = 8).
Fasting plasma lipid levels were determined. Glucose, insulin and C-peptide responses to standard oral glucose tolerance test (OGTT) were measured.
Patients with high PRA had higher levels of plasma cholesterol (6.13 +/- 0.81 versus 4.67 +/- 0.7 mmol L-1, P < 0.05) and triglycerides (2.14 +/- 0.18 versus 0.98 +/- 0.13 mmol L-1, P < 0.05), than the low PRA group. HDL-cholesterol levels were lower in the high renin group than in the low renin group (1.05 +/- 0.04 versus 1.26 +/- 0.09 mmol L-1, P < 0.05). Insulin and C-peptide sums were higher in high PRA group (33.8 +/- 1.2 versus 25.1 +/- 0.9 and 2.6 +/- 0.3 versus 1.9 +/- 0.4 ng L-1, P < 0.05), than in the low PRA group.
Essential hypertensive patients with a high renin profile display more pronounced dyslipidaemia and higher levels of plasma insulin than patients with a low renin profile. This may be one explanation for higher incidence of cardiovascular disease previously reported in high PRA group.
研究原发性高血压患者血浆肾素活性与代谢性心血管危险因素之间的关系。
对36例舒张压为95 - 115 mmHg的单纯原发性高血压患者进行研究。通过评估与尿钠排泄相关的血浆肾素活性(PRA)来定义高肾素水平组(n = 12)、中肾素水平组(n = 16)和低肾素水平组(n = 8)。
测定空腹血脂水平。测量标准口服葡萄糖耐量试验(OGTT)后的血糖、胰岛素和C肽反应。
高PRA组患者的血浆胆固醇水平(6.13±0.81对4.67±0.7 mmol/L,P < 0.05)和甘油三酯水平(2.14±0.18对0.98±0.13 mmol/L,P < 0.05)高于低PRA组。高肾素组的高密度脂蛋白胆固醇水平低于低肾素组(1.05±0.04对1.26±0.09 mmol/L,P < 0.05)。高PRA组的胰岛素和C肽总和高于低PRA组(33.8±1.2对25.1±0.9以及2.6±0.3对1.9±0.4 ng/L,P < 0.05)。
与低肾素水平的原发性高血压患者相比,高肾素水平的患者表现出更明显的血脂异常和更高的血浆胰岛素水平。这可能是先前报道的高PRA组心血管疾病发病率较高的一种解释。